JS019

BIOLOGICAL2 trials

Sponsors

Suzhou Kebo Ruijun Biotechnology Co., Ltd

Conditions

Advanced Solid TumorsAdvanced Solid Tumors or Lymphomas

Phase 1

A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas

Suzhou Kebo Ruijun Biotechnology Co., LtdAdvanced Solid Tumors or Lymphomas

Start: 2022-03-31End: 2024-03-07Target: 172Updated: 2022-05-16

A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors

Suzhou Kebo Ruijun Biotechnology Co., LtdAdvanced Solid Tumors

Start: 2022-03-29End: 2024-08-10Target: 72Updated: 2022-08-19